SponsoredThis article describes biosimilarity assessment approach applicable to comparability of lifecycle assessments and compliant with the US FDA’s totality of evidence concept.
SponsoredAt the CPhI Theater in May 2019, Courtney Morgret, PhD, senior scientist at ABBVIE, shared some key CMC considerations for antibody-drug conjugate products.
SponsoredIn this special report ModiQuest Research applies Intellicyt? iQue technology in its hybridoma screening process. The iQue3 system expedites the discovery of antibodies through improved screening of antigen presentation during stable cell line generation, sera evaluation, and hybridoma selection.